(Total Views: 686)
Posted On: 09/27/2020 9:40:45 AM
Post# of 145247
![Avatar](https://investorshangout.com/images/ProfileImages/167738657_59587_mando klein.jpg)
Re: ClosetInvestor #58104
We'd need to know when the DSMB meets, i.e. when all the preparations for the meeting have been completed. A couple of days after, the company will be able to announce the outcome/recommendation.
With Mesoblast it was within days:
An independent Data Safety Monitoring Board (DSMB) has set a review date of early September for its first interim analysis of the Phase 3 trial of remestemcel-L in ventilator-dependent COVID-19 patients
with moderate to severe ARDS.
PR with recommendation to continue on September 4 .
http://investorsmedia.mesoblast.com/static-fi...66cd51b4d8
With Mesoblast it was within days:
An independent Data Safety Monitoring Board (DSMB) has set a review date of early September for its first interim analysis of the Phase 3 trial of remestemcel-L in ventilator-dependent COVID-19 patients
with moderate to severe ARDS.
PR with recommendation to continue on September 4 .
http://investorsmedia.mesoblast.com/static-fi...66cd51b4d8
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)